Trends in hematological cancer in the elderly in Denmark, 1980-2012

Acta Oncologica
Lukas F OciasAcademy of Geriatric Cancer Research (AgeCare)

Abstract

The number of hematological malignancies is expected to increase as the Danish population ages within the next few decades. Despite this, data on the course of hematological cancers among the oldest patients are sparse with many intervention studies focusing on younger age groups. The aim of this study is to present Danish incidence and mortality rates among older patients with non-Hodgkin lymphomas (NHL), multiple myeloma (MM), chronic lymphocytic leukemia (CLL), and acute myeloid leukemia (AML). Nationwide population-based study presenting the incidence, prevalence and mortality rates of NHL, MM, and AML with a focus on the elderly population in Denmark during the last few decades. Data were drawn from the NORDCAN database. Incidence rates of NHL, MM, CLL and AML were 10-50 times higher among the population aged 70 years or more than among the younger population. An increasing incidence with stable or decreased mortality rates was seen mainly among elderly patients with NHL during the last few decades, leading to increased survival and a greater prevalence of patients with NHL. Increased relative survival and prevalence could also be seen among elderly patients with MM and CLL, while the trends of the incidence rates were inc...Continue Reading

References

Aug 25, 1999·British Journal of Haematology·R A CartwrightK A Gurney
Jan 25, 2002·The New England Journal of Medicine·Bertrand CoiffierChristian Gisselbrecht
Dec 26, 2003·Statistics in Medicine·Paul W DickmanTimo Hakulinen
Apr 28, 2004·Seminars in Oncology·Eric H Westin, Dan L Longo
May 5, 2004·Seminars in Oncology·Elliott F Winton, Amelia A Langston
May 20, 2005·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·M NørgaardH T Sørensen
Dec 24, 2005·British Journal of Haematology·Mette NørgaardHenrik T Sørensen
Feb 22, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·O Mora, E Zucca
Feb 19, 2011·Haematologica·Rafael Marcos-GrageraUNKNOWN HAEMACARE Working Group
Aug 4, 2011·Scandinavian Journal of Public Health·Marianne Lundkjær Gjerstorff
May 30, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Theresa HahnNavneet S Majhail
Jan 10, 2014·The New England Journal of Medicine·Valentin GoedeMichael Hallek
Jan 18, 2014·British Journal of Haematology·Dianne PulteUNKNOWN GEKID Cancer Survival Working Group
Jul 30, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Heidi D KlepinTimothy S Pardee
Jan 20, 2016·Acta Oncologica·Marianne EwertzUNKNOWN Academy of Geriatric Cancer Research (AgeCare)

❮ Previous
Next ❯

Citations

Jan 19, 2019·JAMA Network Open·Marie Joelle JabagiRosemary Dray-Spira
Jun 18, 2020·Clinical Epidemiology·Dennis Lund HansenHenrik Frederiksen
May 6, 2019·Journal of Thrombosis and Haemostasis : JTH·Kasper AdelborgHenrik T Sørensen
Jun 11, 2020·International Journal of Environmental Research and Public Health·Isabella CapodannoLuca Ghirotto
Aug 1, 2020·The British Journal of Ophthalmology·Frederik HolmSteffen Heegaard

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Related Papers

Acta Oncologica
Stine Brændegaard WintherAcademy of Geriatric Cancer Research (AgeCare)
Acta Oncologica
Rikke H DahlrotAcademy of Geriatric Cancer Research (AgeCare)
Acta Oncologica
M EwertzAcademy of Geriatric Cancer Research (AgeCare)
Acta Oncologica
Jeanette D JensenAcademy of Geriatric Cancer Research (AgeCare)
Acta Oncologica
Charlotte KristiansenAcademy of Geriatric Cancer Research (AgeCare)
© 2022 Meta ULC. All rights reserved